Continuous positive airway pressure therapy decreases evening cortisol concentrations in patients with severe obstructive sleep apnea

Metabolism: Clinical and Experimental

Volumn 58, Issue 6, 2009, Pages 848-853

  Schmoller, Andre ^a   Eberhardt, Frank ^a,b   Jauch Chara, Kamila ^a   Schweiger, Ulrich ^a   Zabel, Peter ^a,b   Peters, Achim ^a   Schultes, Bernd ^a,c   Oltmanns, Kerstin M ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c Interdisciplinary Obesity Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; LACTIC ACID;

AIRWAY PRESSURE; APNEA; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXIA; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SALIVA LEVEL; SLEEP APNEA SYNDROME;

ANOXIA; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; SALIVA; SLEEP APNEA, OBSTRUCTIVE;

EID: 65549131086     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.02.014     Document Type: Article

References (41)

1. Woodson B.T. Surgical approaches to obstructive sleep apnea. Curr Opin Pulm Med 4 (1998) 344-350
2. Ekstedt M., Akerstedt T., and Soderstrom M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure. Psychosom Med 66 (2004) 925-931
3. Verse T., Pirsig W., Stuck B.A., et al. Recent developments in the treatment of obstructive sleep apnea. Am J Respir Med 2 (2003) 157-168
4. Struder H.K., Hollmann W., Donike M., et al. Effect of O2 availability on neuroendocrine variables at rest and during exercise: O2 breathing increases plasma prolactin. Eur J Appl Physiol Occup Physiol 74 (1996) 443-449
5. Ziegler M.G., Mills P.J., Loredo J.S., et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120 (2001) 887-893
6. Grunstein R.R., Handelsman D.J., Lawrence S.J., et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 68 (1989) 352-358
7. Grunstein R.R., Stewart D.A., Lloyd H., et al. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 19 (1996) 774-782
8. Entzian P., Linnemann K., Schlaak M., et al. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 153 (1996) 1080-1086
9. Bratel T., Wennlund A., and Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93 (1999) 1-7
10. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 13 (1997) 65
11. Gianotti L., Pivetti S., Lanfranco F., et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 87 (2002) 5052-5057
12. Jessop D.S., Dallman M.F., Fleming D., et al. Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 86 (2001) 4109-4114
13. Dallman M.F., la Fleur S.E., Pecoraro N.C., et al. Minireview: glucocorticoids-food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology 145 (2004) 2633-2638
14. Oltmanns K.M., Dodt B., Schultes B., et al. Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients. Eur J Endocrinol 154 (2006) 325-331
15. Buckley T.M., and Schatzberg A.F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90 (2005) 3106-3114
16. Robergs R.A., Ghiasvand F., and Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 287 (2004) R502-R516
17. Brooks G.A. Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc 17 (1985) 22-34
18. McArdle N., Devereux G., Heidarnejad H., et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159 (1999) 1108-1114
19. Vining R.F., McGinley R.A., Maksvytis J.J., et al. Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem 20 Pt 6 (1983) 329-335
20. Westermann J., Demir A., and Herbst V. Determination of cortisol in saliva and serum by a luminescence-enhanced enzyme immunoassay. Clin Lab 50 (2004) 11-24
21. Kirschbaum C., and Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19 (1994) 313-333
22. Vgontzas A.N., Pejovic S., Zoumakis E., et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 92 (2007) 4199-4207
23. Dadoun F., Darmon P., Achard V., et al. Effect of sleep apnoea syndrome on the circadian profile of cortisol in obese men. Am J Physiol Endocrinol Metab (2007)
24. Lanfranco F., Gianotti L., Pivetti S., et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) 60 (2004) 41-48
25. Meston N., Davies R.J., Mullins R., et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 254 (2003) 447-454
26. Chin K., Shimizu K., Nakamura T., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 (1999) 706-712
27. Raff H., Raff J.L., and Findling J.W. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 83 (1998) 2681-2686
28. Born J., and Fehm H.L. Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes 106 (1998) 153-163
29. Gavrila A., Peng C.K., Chan J.L., et al. Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab 88 (2003) 2838-2843
30. Plat L., Leproult R., L'Hermite-Baleriaux M., et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab 84 (1999) 3082-3092
31. Deuschle M., Schweiger U., Weber B., et al. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82 (1997) 234-238
32. Fehm H.L., Holl R., Klein E., et al. The meal-related peak in plasma cortisol is not mediated by radioimmunoassayable ACTH. Clin Physiol Biochem 1 (1983) 329-333
33. Follenius M., Brandenberger G., and Hietter B. Diurnal cortisol peaks and their relationships to meals. J Clin Endocrinol Metab 55 (1982) 757-761
34. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
35. Vgontzas A.N., and Chrousos G.P. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am 31 (2002) 15-36
36. Vgontzas A.N., Zoumakis E., Lin H.M., et al. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 89 (2004) 4409-4413
37. Homma M., Tanaka A., Hino K., et al. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure. Metabolism 50 (2001) 801-804
38. Bjorntorp P., and Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord 24 Suppl 2 (2000) S80-S85
39. Cooper B.G., White J.E., Ashworth L.A., et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18 (1995) 172-179
40. Vanuxem D., Badier M., Guillot C., et al. Impairment of muscle energy metabolism in patients with sleep apnoea syndrome. Respir Med 91 (1997) 551-557
41. Bonanni E., Pasquali L., Manca M.L., et al. Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients. Sleep Med 5 (2004) 137-145